These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 17766011

  • 1. MIF-1 and its peptidomimetic analogs attenuate haloperidol-induced vacuous chewing movements and modulate apomorphine-induced rotational behavior in 6-hydroxydopamine-lesioned rats.
    Castellano JM, Batrynchuk J, Dolbeare K, Verma V, Mann A, Skoblenick KJ, Johnson RL, Mishra RK.
    Peptides; 2007 Oct; 28(10):2009-15. PubMed ID: 17766011
    [Abstract] [Full Text] [Related]

  • 2. Modulation of dopaminergic neurotransmission in the 6-hydroxydopamine lesioned rotational model by peptidomimetic analogues of L-prolyl-L-leucyl-glycinamide.
    Ott MC, Mishra RK, Johnson RL.
    Brain Res; 1996 Oct 21; 737(1-2):287-91. PubMed ID: 8930377
    [Abstract] [Full Text] [Related]

  • 3. Pro-Leu-glycinamide and its peptidomimetic, PAOPA, attenuate haloperidol induced vacuous chewing movements in rat: A model of human tardive dyskinesia.
    Sharma S, Paladino P, Gabriele J, Saeedi H, Henry P, Chang M, Mishra RK, Johnson RL.
    Peptides; 2003 Feb 21; 24(2):313-9. PubMed ID: 12668218
    [Abstract] [Full Text] [Related]

  • 4. Modulation of dopamine receptor agonist-induced rotational behavior in 6-OHDA-lesioned rats by a peptidomimetic analogue of Pro-Leu-Gly-NH2 (PLG).
    Mishra RK, Marcotte ER, Chugh A, Barlas C, Whan D, Johnson RL.
    Peptides; 1997 Feb 21; 18(8):1209-15. PubMed ID: 9396063
    [Abstract] [Full Text] [Related]

  • 5. The effects of prolyl-leucyl-glycine amide on drug-induced rotation in lesioned rats.
    Smith JR, Morgan M.
    Gen Pharmacol; 1982 Feb 21; 13(3):203-7. PubMed ID: 6124481
    [Abstract] [Full Text] [Related]

  • 6. L-prolyl-l-leucyl-glycinamide and its peptidomimetic analog 3(R)-[(2(S)-pyrrolidylcarbonyl)amino]-2-oxo-1-pyrrolidineacetamide (PAOPA) attenuate haloperidol-induced c-fos expression in the striatum.
    Ott MC, Costain WJ, Mishra RK, Johnson RL.
    Peptides; 2000 Feb 21; 21(2):301-8. PubMed ID: 10764960
    [Abstract] [Full Text] [Related]

  • 7. Potentiation of apomorphine-induced stereotypies by naloxone and L-prolyl-L-leucyl-glycinamide.
    Quock RM, Lucas TS, Hartl TJ.
    Pharmacol Biochem Behav; 1983 Jul 21; 19(1):49-52. PubMed ID: 6137836
    [Abstract] [Full Text] [Related]

  • 8. Modulatory effects of PLG and its peptidomimetics on haloperidol-induced catalepsy in rats.
    Costain WJ, Buckley AT, Evans MC, Mishra RK, Johnson RL.
    Peptides; 1999 Jul 21; 20(6):761-7. PubMed ID: 10477133
    [Abstract] [Full Text] [Related]

  • 9. MSH and MIF-I in animal models of tardive dyskinesia.
    Davis KL, Kastin AJ, Beilstein BA, Vento AL.
    Pharmacol Biochem Behav; 1980 Jul 21; 13(1):37-40. PubMed ID: 6105677
    [Abstract] [Full Text] [Related]

  • 10. Electron spin resonance spectroscopy reveals alpha-phenyl-N-tert-butylnitrone spin-traps free radicals in rat striatum and prevents haloperidol-induced vacuous chewing movements in the rat model of human tardive dyskinesia.
    Rogoza RM, Fairfax DF, Henry P, N-Marandi S, Khan RF, Gupta SK, Mishra RK.
    Synapse; 2004 Dec 01; 54(3):156-63. PubMed ID: 15452862
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and dopamine receptor modulating activity of novel peptidomimetics of L-prolyl-L-leucyl-glycinamide featuring alpha,alpha-disubstituted amino acids.
    Evans MC, Pradhan A, Venkatraman S, Ojala WH, Gleason WB, Mishra RK, Johnson RL.
    J Med Chem; 1999 Apr 22; 42(8):1441-7. PubMed ID: 10212130
    [Abstract] [Full Text] [Related]

  • 12. MIF-1 attenuates apomorphine stereotypies in adult rats after neonatal 6-hydroxydopamine.
    Kostrzewa RM, White TG, Zadina JE, Kastin AJ.
    Eur J Pharmacol; 1989 Apr 12; 163(1):33-42. PubMed ID: 2568266
    [Abstract] [Full Text] [Related]

  • 13. Effect of acute L-Dopa pretreatment on apomorphine-induced rotational behavior in a rat model of Parkinson's disease.
    Mandel RJ.
    Exp Neurol; 2000 Jan 12; 161(1):212-9. PubMed ID: 10683287
    [Abstract] [Full Text] [Related]

  • 14. Design, synthesis, and dopamine receptor modulating activity of diketopiperazine peptidomimetics of L-prolyl-L-leucylglycinamide.
    Baures PW, Ojala WH, Costain WJ, Ott MC, Pradhan A, Gleason WB, Mishra RK, Johnson RL.
    J Med Chem; 1997 Oct 24; 40(22):3594-600. PubMed ID: 9357526
    [Abstract] [Full Text] [Related]

  • 15. MIF-1 fails to modify agonist-induced oral activity in neonatal 6-OHDA-treated rats.
    Gong L, Kostrzewa RM, Kalbfleisch JH.
    Peptides; 1993 Oct 24; 14(6):1159-64. PubMed ID: 7907787
    [Abstract] [Full Text] [Related]

  • 16. Effects of chronic haloperidol and clozapine on vacuous chewing and dopamine-mediated jaw movements in rats: evaluation of a revised animal model of tardive dyskinesia.
    Ikeda H, Adachi K, Hasegawa M, Sato M, Hirose N, Koshikawa N, Cools AR.
    J Neural Transm (Vienna); 1999 Oct 24; 106(11-12):1205-16. PubMed ID: 10651114
    [Abstract] [Full Text] [Related]

  • 17. [Dependence of the effects of tripeptide MIF and lithium chloride on the degree of supersensitivity of dopamine receptors of the brain].
    Bondarenko NA, Val'dman AV.
    Biull Eksp Biol Med; 1989 Aug 24; 108(8):196-9. PubMed ID: 2553154
    [Abstract] [Full Text] [Related]

  • 18. Molsidomine, a nitric oxide donor, modulates rotational behavior and monoamine metabolism in 6-OHDA lesioned rats treated chronically with L-DOPA.
    Lorenc-Koci E, Czarnecka A, Lenda T, Kamińska K, Konieczny J.
    Neurochem Int; 2013 Dec 24; 63(8):790-804. PubMed ID: 24090640
    [Abstract] [Full Text] [Related]

  • 19. Increased S(-)-apomorphine-induced vacuous chewing and attenuated effect of chronic haloperidol treatment in streptozotocin-induced diabetic rat.
    Sumiyoshi T, Ichikawa J, Meltzer HY.
    Pharmacol Biochem Behav; 1997 Dec 24; 57(1-2):19-22. PubMed ID: 9164549
    [Abstract] [Full Text] [Related]

  • 20. Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine.
    Sindhu KM, Banerjee R, Senthilkumar KS, Saravanan KS, Raju BC, Rao JM, Mohanakumar KP.
    Pharmacol Biochem Behav; 2006 Jun 24; 84(2):321-9. PubMed ID: 16820197
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.